Cancer drug could aid heart attack recovery, study finds
British Heart Foundation hopes medicines which activate an inflammation-reducing white blood cell will revolutionise treatment, reports Jon Sharman
A cancer drug may help a heart attack patient recover and even reduce the likelihood they will have further attacks, an early-stage study suggests.
Scientists from the University of Cambridge found a low dose of aldesleukin injected under the skin of patients who had suffered an acute heart attack increased the activation of immune cells shown to protect the heart.
Specifically, the drug was shown to activate a rare white blood cell called innate type 2 lymphocyte (ILC2). Ordinarily it is administered to kidney cancer patients to shrink their tumours.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies